MedTrace Logo

TAP Catheters Versus Intrathecal Morphine for Cesarean Section

NCT01593280 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2012-05-08

No results posted yet for this study

Summary

Morphine, when given as part of spinal anesthesia, is associated high incidence of nausea and pruritus, which may affect quality of recovery. The investigators hypothesize that long-acting local anesthetic infusions via TAP catheter can provide better quality of recovery after cesarean section than spinal morphine.

Conditions

  • Abdominal Muscles/Ultrasonography
  • Adult
  • Anesthetics, Local/Administration & Dosage
  • Ropivacaine/Administration & Dosage
  • Ropivacaine/Analogs & Derivatives
  • Cesarean Section
  • Humans
  • Nerve Block/Methods
  • Pain Measurement/Methods
  • Pain, Postoperative/Prevention & Control
  • Ultrasonography, Interventional

Interventions

DEVICE

TAP catheter

dosed with 20ml of Ropivacaine 0.5% at that time. Double lumen pump containing 700 ml of the Ropivacaine 0.2% will be attached to the TAP catheters in the recovery room. The time that this occurs will be recorded in the eMAR. The catheters will run at 7cc/hr/side for 50 hrs.

DRUG

intrathecal morphine

0.3 mg

Sponsors & Collaborators

  • I-Flow

    collaborator INDUSTRY

  • Stamford Anesthesiology Services, PC

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2013-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01593280 on ClinicalTrials.gov